BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shin YH, Shin JI, Moon SY, Jin HY, Kim SY, Yang JM, Cho SH, Kim S, Lee M, Park Y, Kim MS, Won HH, Hong SH, Kronbichler A, Koyanagi A, Jacob L, Smith L, Lee KH, Suh DI, Lee SW, Yon DK. Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study. Lancet Rheumatol 2021. [PMID: 34179832 DOI: 10.1016/S2665-9913(21)00151-X] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 24.0] [Reference Citation Analysis]
Number Citing Articles
1 Isnardi CA, Roberts K, Saurit V, Petkovic I, Báez RM, Quintana R, Tissera Y, Ornella S, D Angelo Exeni ME, Pisoni CN, Castro Coello VV, Berbotto G, Haye Salinas MJ, Velozo E, Reyes Torres ÁA, Tanten R, Zelaya MD, Gobbi C, Alonso CG, de Los Ángeles Severina M, Vivero F, Paula A, Cogo AK, Alle G, Pera M, Nieto RE, Cosatti M, Asnal C, Pereira D, Albiero JA, Savio VG, Maldonado FN, Gamba MJ, Germán NF, Baños A, Gallino Yanzi J, Gálvez Elkin MS, Morbiducci JS, Martire MV, Maldonado Ficco H, Schmid MM, Villafañe Torres JA, de Los Ángeles Correa M, Medina MA, Cusa MA, Scafati J, Agüero SE, Lloves Schenone NM, Soriano ER, Graf C, Pons-Estel BA, Gomez G, Landi M, De la Vega MC, Pons-Estel GJ; S. A. R.–COVID Registry Investigators. Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry. Clin Rheumatol 2022. [PMID: 36201124 DOI: 10.1007/s10067-022-06393-8] [Reference Citation Analysis]
2 Auroux M, Laurent B, Coste B, Massy E, Mercier A, Durieu I, Confavreux CB, Lega J, Mainbourg S, Coury F. Réponse sérologique après vaccination contre le coronavirus chez les patients atteints de rhumatisme inflammatoire chronique traités par DMARDs : étude de cohorte et revue systématique avec méta-analyse. Revue du Rhumatisme 2022;89:435-446. [DOI: 10.1016/j.rhum.2022.07.002] [Reference Citation Analysis]
3 Kihara M, Sugihara T, Asano J, Sato M, Kaneko H, Muraoka S, Ohshima S, Nanki T. Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry. Clin Rheumatol 2022. [PMID: 35974224 DOI: 10.1007/s10067-022-06305-w] [Reference Citation Analysis]
4 Perico N, Cortinovis M, Suter F, Remuzzi G. Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents. The Lancet Infectious Diseases 2022. [DOI: 10.1016/s1473-3099(22)00433-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Marozoff S, Lu N, Loree JM, Xie H, Lacaille D, Kopec JA, Esdaile J, Aviña-zubieta JA. Severe COVID-19 outcomes among patients with autoimmune rheumatic diseases or transplantation: a population-based matched cohort study. BMJ Open 2022;12:e062404. [DOI: 10.1136/bmjopen-2022-062404] [Reference Citation Analysis]
6 Dong L, Umehara H, Zhong J. Editorial: Rheumatic Diseases and Infection. Front Med (Lausanne) 2022;9:941678. [PMID: 35721091 DOI: 10.3389/fmed.2022.941678] [Reference Citation Analysis]
7 Schaffer AL, Henry D, Zoega H, Elliott JH, Pearson S. Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia. PLoS ONE 2022;17:e0269482. [DOI: 10.1371/journal.pone.0269482] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Kim SY, Yeniova AÖ. Global, regional, and national incidence and mortality of COVID-19 in 237 countries and territories, January 2022: a systematic analysis for World Health Organization COVID-19 Dashboard. Life Cycle 2022;2. [DOI: 10.54724/lc.2022.e10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Fragoulis GE, Bournia VK, Sfikakis PP. Different systemic rheumatic diseases as risk factors for COVID-19-related mortality. Clin Rheumatol 2022. [PMID: 35499772 DOI: 10.1007/s10067-022-06190-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Mazaheri T, Ranasinghe R, Al-hasani W, Luxton J, Kearney J, Manning A, Dimitriadis GK, Mare T, Vincent RP. A cytokine panel and procalcitonin in COVID-19, a comparison between intensive care and non-intensive care patients. PLoS ONE 2022;17:e0266652. [DOI: 10.1371/journal.pone.0266652] [Reference Citation Analysis]
11 Lee SW, Koo MJ. PRISMA 2020 statement and guidelines for systematic review and meta-analysis articles, and their underlying mathematics: Life Cycle Committee Recommendations. Life Cycle 2022;2. [DOI: 10.54724/lc.2022.e9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Bournia V, Fragoulis GE, Mitrou P, Mathioudakis K, Tsolakidis A, Konstantonis G, Tseti I, Vourli G, Tektonidou MG, Paraskevis D, Sfikakis PP. Different Covid-19 Outcomes Among Systemic Rheumatic Diseases: A Nation-wide Cohort Study.. [DOI: 10.1101/2022.03.11.22271887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Grainger R, Kim AHJ, Conway R, Yazdany J, Robinson PC. COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations. Nat Rev Rheumatol 2022. [PMID: 35217850 DOI: 10.1038/s41584-022-00755-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 26.0] [Reference Citation Analysis]
14 Valladales-restrepo LF, Machado-duque ME, Gaviria-mendoza A, Ospina-arzuaga HD, Ruiz-zapata M, Machado-alba JE. Incidence and factors related to SARS-CoV-2 infection in a cohort of patients with rheumatoid arthritis from a health service provider in Colombia during the COVID-19 pandemic. Therapeutic Advances in Infection 2022;9:204993612211351. [DOI: 10.1177/20499361221135155] [Reference Citation Analysis]
15 Ozcifci G, Aydin T, Atli Z, Balkan II, Tabak F, Oztas M, Ozguler Y, Ugurlu S, Hatemi G, Melikoglu M, Fresko I, Hamuryudan V, Seyahi E. The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet's syndrome. Rheumatol Int 2021. [PMID: 34825278 DOI: 10.1007/s00296-021-05056-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Yoo HW, Jin HY, Yon DK, Effenberger M, Shin YH, Kim SY, Yang JM, Kim MS, Koyanagi A, Jacob L, Smith L, Yoo IK, Shin JI, Lee SW. Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort. J Korean Med Sci 2021;36:e291. [PMID: 34697932 DOI: 10.3346/jkms.2021.36.e291] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
17 Park HY, Song IA, Lee SH, Sim MY, Oh HS, Song KH, Yu ES, Park HY, Oh TK. Prevalence of mental illness among COVID-19 survivors in South Korea: nationwide cohort. BJPsych Open 2021;7:e183. [PMID: 34659793 DOI: 10.1192/bjo.2021.1001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
18 Lee SW, Kim SY, Moon SY, Yoo IK, Yoo EG, Eom GH, Kim JM, Shin JI, Jeong MH, Yang JM, Yon DK. Statin Use and COVID-19 Infectivity and Severity in South Korea: Two Population-Based Nationwide Cohort Studies. JMIR Public Health Surveill 2021;7:e29379. [PMID: 34623311 DOI: 10.2196/29379] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
19 Jung Y, Kwon M, Choi HG. Association between previous rheumatoid arthritis and COVID-19 and its severity: a nationwide cohort study in South Korea. BMJ Open 2021;11:e054753. [PMID: 34620675 DOI: 10.1136/bmjopen-2021-054753] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
20 Kang SH, Cho DH, Choi J, Baik SK, Gwon JG, Kim MY. Association between chronic hepatitis B infection and COVID-19 outcomes: A Korean nationwide cohort study. PLoS One 2021;16:e0258229. [PMID: 34610052 DOI: 10.1371/journal.pone.0258229] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
21 Rutter M, Lanyon PC, Grainge MJ, Hubbard R, Peach E, Bythell M, Stilwell P, Aston J, Stevens S, Pearce FA. COVID-19 Infection, Admission and Death Amongst People with Rare Autoimmune Rheumatic Disease in England. Results from the RECORDER Project.. [DOI: 10.1101/2021.08.17.21260846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Lee SW, Lee J, Moon SY, Jin HY, Yang JM, Ogino S, Song M, Hong SH, Abou Ghayda R, Kronbichler A, Koyanagi A, Jacob L, Dragioti E, Smith L, Giovannucci E, Lee IM, Lee DH, Lee KH, Shin YH, Kim SY, Kim MS, Won HH, Ekelund U, Shin JI, Yon DK. Physical activity and the risk of SARS-CoV-2 infection, severe COVID-19 illness and COVID-19 related mortality in South Korea: a nationwide cohort study. Br J Sports Med 2021:bjsports-2021-104203. [PMID: 34301715 DOI: 10.1136/bjsports-2021-104203] [Cited by in Crossref: 39] [Cited by in F6Publishing: 47] [Article Influence: 39.0] [Reference Citation Analysis]